Pages with the most revisions

Showing below up to 50 results in range #1,951 to #2,000.

View ( | ) (20 | 50 | 100 | 250 | 500)

  1. 22. IgA nephropathy, chronic glomerulonephritis. Glomerular lesions associated with systemic disorders (SLE, Henoch-Schönlein purpura, Wegener’s granulomatosis, amyloidosis)‏‎ (1 revision)
  2. 13. Acoustic tumours, noise induced hearing losses‏‎ (1 revision)
  3. 49. Mechanisms of vasoconstriction and vasodilatation‏‎ (1 revision)
  4. 33. Epinephrine and glucagon‏‎ (1 revision)
  5. Prostate biopsy‏‎ (1 revision)
  6. IgA vasculitis‏‎ (1 revision)
  7. 8. Differentiation and derivatives of the pharyngeal pouches and clefts. Malformations‏‎ (1 revision)
  8. 23. Cohort studies‏‎ (1 revision)
  9. 13. Laboratory analysis of plasma enzymes‏‎ (1 revision)
  10. 5. Innate immunity, pattern recognition‏‎ (1 revision)
  11. 34. Intravascular radiologic interventions II. Interventional radiologic treatment of bleeding, vasoocclusive techniques (embolization, sclerotisation).‏‎ (1 revision)
  12. Radiation biology‏‎ (1 revision)
  13. B1. Genital fistulas – pathomechanism, diagnosis and therapy‏‎ (1 revision)
  14. 82. Pharmacogenetics, pharmacogenomics. Effects of age, diet and disease on drug action‏‎ (1 revision)
  15. 14. Epidemiology and prevention of colorectal cancer‏‎ (1 revision)
  16. 50. Causes and consequences of increased airway resistance – causes and consequences of chronic obstructive pulmonary disease (COPD) – emphysema‏‎ (1 revision)
  17. 35. Image-guided biopsies. Cyst puncture, drainage (biliary, renal, bladder etc.)‏‎ (1 revision)
  18. Retinitis pigmentosa‏‎ (1 revision)
  19. Joint replacement‏‎ (1 revision)
  20. Chronic lymphocytic leukaemia (CLL) and small lymphocytic lymphoma (SLL)‏‎ (1 revision)
  21. B12. Diverticulosis and diverticulitis‏‎ (1 revision)
  22. 9. Cancer pain management‏‎ (1 revision)
  23. 24. Pulmonary circulation, pulmonary hypertension‏‎ (1 revision)
  24. 15. Causation in epidemiology: association and causation‏‎ (1 revision)
  25. 51. Toxicology tests in the clinical laboratory‏‎ (1 revision)
  26. 36. Laboratory diagnosis and monitoring of malignant and inflammatory bowel diseases‏‎ (1 revision)
  27. Left atrial enlargement‏‎ (1 revision)
  28. Codman triangle‏‎ (1 revision)
  29. 9. The intestinal tube and its derivatives (with the exception of the pharyngeal gut). Malformations‏‎ (1 revision)
  30. 25. Meta-analysis, systematic review‏‎ (1 revision)
  31. 15. Pathomechanism and clinicopathological forms of stone formation‏‎ (1 revision)
  32. 53. Pathology of the valvular disorders (inflammatory and degenerative ones)‏‎ (1 revision)
  33. B18. Pelvic organ prolapse; therapy‏‎ (1 revision)
  34. A10. Urinary tract imaging: Purpose, and indications‏‎ (1 revision)
  35. 26. Epidemiology and prevention of inflammatory bowel diseases‏‎ (1 revision)
  36. 16. Imaging of the pancreas and the spleen. Imaging techniques, indications, information content.‏‎ (1 revision)
  37. 55. Opioid analgesic drugs. Morphine and codeine‏‎ (1 revision)
  38. 38. New infectious diseases. Bioterrorism‏‎ (1 revision)
  39. Substance-or-Medication-Induced Psychotic Disorder‏‎ (1 revision)
  40. A13. The criteria and the potential complications of IUD usage‏‎ (1 revision)
  41. 57. Polycythemias, polyglobulias‏‎ (1 revision)
  42. 3A. Differential diagnosis of tremors‏‎ (1 revision)
  43. Merkel cell carcinoma‏‎ (1 revision)
  44. Dipyridamole‏‎ (1 revision)
  45. B25. Management and medical treatment of patients with urinary stones‏‎ (1 revision)
  46. A16. Classifications of malignant tumors. TNM-grading.‏‎ (1 revision)
  47. 59. Pathology of pregnancy I (implantation disorders, gestosis, trophoblastic tumours)‏‎ (1 revision)
  48. 17. Tissue hypoxia, ischemia, reperfusion and tissue metabolism‏‎ (1 revision)
  49. 4. Other modifiable risk factors of coronary heart disease‏‎ (1 revision)
  50. Thyrotoxic crisis‏‎ (1 revision)

View ( | ) (20 | 50 | 100 | 250 | 500)